title: Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia.
abstract: Multidrug resistance gene 1 (MDR1) is known for its involvement in the detoxification through the active transport of toxic compounds from diverse origins outside the cells. These compounds could cause injury to cell DNA, which might lead in cancer like chronic myeloid leukemia (CML). Individual inherited genetic differences related to polymorphism in detoxification enzymes could be an important factor not only in carcinogen metabolism but also in susceptibility of cancer. The present study aimed to investigate the association of three single nucleotide polymorphisms (SNPs) of the MDR1 gene in the susceptibility of CML. We successively have determined the genotype profiles of 1236 C>T (exon 12); 2677 G>T (exon 21), and 3435 C>T (exon 26) SNPs by PCR-RFLP in 89 patients and 99 unrelated healthy controls. Logistic regression was used to assess the effect of each SNP on the development of CML. Interestingly, in exon 12, the 1236 TT was significantly associated with the susceptibility of CML when compared to the wild type 1236 CC (OR 2.7; 95% CI 1-7.32, p = 0.041). Additionally, the recessive model 1236 TT vs. 1236 CC/CT showed a risk of 3.3 fold (p = 0.011) with CML. In exon 26, the 3435 CT genotype was associated with a reduced risk of CML (OR 0.5; 95% CI 0.3-1, p = 0.042). In exon 21, the 2677 GT genotype seems to have a protective effect (OR 0.6; 95% CI 0.32-1.1, p = 0.074). Diplolotypes analysis has demonstrated no effect in susceptibility of CML, but 1236 CT/3435 CC and 1236 CC/2677 GT were associated with a protective effect. The haplotypes analysis showed no particular trend (global association p = 0.33). Our findings demonstrate that 1236 TT in exon 12 might contribute in the susceptibility of CML, while the 3435 CT in exon 26 as well as 1236 CT/3435 CC and 1236 CC/2677 GT combinations might be protective factors.
authors.affiliation: Genetics and Molecular Pathology Laboratory, Medical school of Casablanca, University Hassan II, 19 Rue Tarik Ibnou Ziad, BP., 9154, Casablanca, Morocco, kassoy2@yahoo.fr.
authors.forename: Kassogue
authors.initials: K
authors.lastname: Yaya
authors.forename: Dehbi
authors.initials: D
authors.lastname: Hind
authors.forename: Quachouh
authors.initials: Q
authors.lastname: Meryem
authors.forename: Quessar
authors.initials: Q
authors.lastname: Asma
authors.forename: Benchekroun
authors.initials: B
authors.lastname: Said
authors.forename: Nadifi
authors.initials: N
authors.lastname: Sellama
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B / Q000235:genetics; D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011379:Prognosis; D012307:Risk Factors; D055815:Young Adult
chemical_list: C513055:ABCB1 protein, human; D018435:ATP Binding Cassette Transporter, Subfamily B
references.citation: Proc Natl Acad Sci U S A. 1987 Jan;84(1):265-9
references.pmid: 2432605
references.citation: Science. 2006 Dec 22;314(5807):1930-3
references.pmid: 17185601
references.citation: Blood. 2005 Apr 1;105(7):2640-53
references.pmid: 15618470
references.citation: Clin Pharmacol Ther. 2004 Jan;75(1):13-33
references.pmid: 14749689
references.citation: Annu Rev Physiol. 2003;65:261-311
references.pmid: 12518001
references.citation: Blood. 1998 Mar 1;91(5):1749-56
references.pmid: 9473242
references.citation: Pharmacogenetics. 2001 Jun;11(4):293-8
references.pmid: 11434506
references.citation: BMC Cancer. 2009 Nov 21;9:407
references.pmid: 19930591
references.citation: J Clin Oncol. 2003 Apr 15;21(8):1637-47
references.pmid: 12668652
references.citation: Blood. 2000 Nov 15;96(10):3343-56
references.pmid: 11071626
references.citation: BMC Gastroenterol. 2013 Mar 27;13:57
references.pmid: 23537364
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1172-7
references.pmid: 17548681
references.citation: Pharmacol Rep. 2006 Sep-Oct;58(5):720-8
references.pmid: 17085864
references.citation: Drug Metab Pharmacokinet. 2004 Feb;19(1):1-14
references.pmid: 15499164
references.citation: Toxicology. 2002 Dec 27;181-182:299-303
references.pmid: 12505329
references.citation: Eur J Haematol. 2004 May;72(5):314-21
references.pmid: 15059065
references.citation: Br J Haematol. 2000 Jul;110(1):2-11
references.pmid: 10930974
references.citation: Leuk Res. 2009 Feb;33(2):332-5
references.pmid: 18639335
references.citation: Haematologica. 2002 Jun;87(6):564-8
references.pmid: 12031911
references.citation: Cancer Res. 2007 Oct 15;67(20):9609-12
references.pmid: 17942888
references.citation: Blood Cells Mol Dis. 2012 Feb 15;48(2):132-6
references.pmid: 22134106
references.citation: Clin Pharmacol Ther. 2001 Aug;70(2):189-99
references.pmid: 11503014
references.citation: Blood. 2003 Jul 1;102(1):276-83
references.pmid: 12623848
references.citation: DNA Cell Biol. 2013 Oct;32(10):582-8
references.pmid: 23930592
references.citation: J Histochem Cytochem. 1989 Feb;37(2):159-64
references.pmid: 2463300
references.citation: Nucleic Acids Res. 1988 Feb 11;16(3):1215
references.pmid: 3344216
references.citation: Hematology. 2014 Apr;19(3):123-8
references.pmid: 23683876
references.citation: Drug Metab Pharmacokinet. 2006 Aug;21(4):257-76
references.pmid: 16946553
references.citation: J Biol Chem. 1987 Dec 25;262(36):17432-6
references.pmid: 2891692
references.citation: Srp Arh Celok Lek. 2010 May-Jun;138(5-6):305-8
references.pmid: 20607973
references.citation: Biochemistry (Mosc). 2008 May;73(5):543-54
references.pmid: 18605979
references.citation: Bioinformatics. 2006 Aug 1;22(15):1928-9
references.pmid: 16720584
references.citation: PLoS One. 2011;6(9):e24381
references.pmid: 21931700
references.citation: Arch Pharm Res. 2005 Mar;28(3):249-68
references.pmid: 15832810
references.citation: Radiat Res. 1994 Feb;137(2 Suppl):S68-97
references.pmid: 8127953
references.citation: Swiss Med Wkly. 2008 Jan 12;138(1-2):12-7
references.pmid: 18224491